Crinetics Pharmaceuticals, Inc. (CRNX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$6.04M2017: -$9.13M2018: -$28.71M2019: -$53.83M2020: -$74.95M2021: -$107.70M2022: -$167.88M2023: -$222.61M2024: -$338.85M2025: -$516.77M-$516.77M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$516.77M-52.5%
2024-$338.85M-52.2%
2023-$222.61M-32.6%
2022-$167.88M-55.9%
2021-$107.70M-43.7%
2020-$74.95M-39.2%
2019-$53.83M-87.5%
2018-$28.71M-214.6%
2017-$9.13M-51.0%
2016-$6.04M